Marketing Authorisation Suspension Product For Human Use «Alendronate Ranbaxy Italy».

Original Language Title: Sospensione dell'autorizzazione all'immissione in commercio delmedicinale per uso umano «Alendronato Ranbaxy Italia».

Read the untranslated law here: http://www.gazzettaufficiale.it/atto/serie_generale/caricaArticoloDefault/originario?atto.dataPubblicazioneGazzetta=2015-02-13&atto.codiceRedazionale=15A00925&elenco30giorni=false&atto.tipoProvvedimento=DECRETO

With the determination # aSM-10/2015-2826 of January 23, 2015 she was suspended, pursuant to article 133, paragraph 3 and 141, paragraph 5 of Legislative Decree no April 24, 2006. 219, the authorisation for the medicinal product ALENDRONATE RANBAXY Italy.
Packaging: 038006122-"70 mg tablets" 12 tablets in pa/al/pvc/al;
038006134-"70 mg tablets" 40 tablets in pa/al/pvc/al;
038006096-"70 mg tablets" 2 tablets in pa/al/pvc/al;
038006110-"70 mg tablets" 8 tablets in pa/al/pvc/al;
038006108-"70 mg tablets" 4 tablets in pa/al/pvc/al, firm Ranbaxy Italy S.p.A.